Literature DB >> 9410236

[Selective excimer laser ablation of the trabecular meshwork. Clinical results].

M Vogel1, K Lauritzen.   

Abstract

PURPOSE: Examination of the efficacy of pore formation in the trabecular meshwork by excimer laser to reduce intraocular pressure in glaucoma eyes. PATIENTS AND METHODS: In 27 consecutive eyes with chronic simple glaucoma and 8 eyes with low-tension glaucoma, 3 to 5 pores were ablated into the trabecular meshwork with an excimer laser (308 nm, 35-55 mJ/mm2), creating an open communication between the anterior chamber and Schlemm's canal. This was accomplished by the use of a 400-micron quartz fiber and a modified Trokel goniolens. All patients were candidates for trabeculectomy because visual fields continued to deteriorate in spite of maximum medication.
RESULTS: Intraocular pressure was median reduced by 7 mmHg (range 10.5 to 1.5 mmHg) in 22 of 27 eyes with chronic simple glaucoma over a median follow-up of 7 months. In 12 eyes, further medication has to be continued, yet at a lower dose and lower level of intraocular pressure. In five eyes therapy failed. In three of these eyes, a trabeculectomy had to be performed. In eight eyes with low-tension glaucoma, a median reduction of intraocular pressure of 5 mmHg (range 10 to 0.5 mmHg) was accomplished over a median follow-up of 7 months. In five of these eyes, further medication on a lower level was continued. No further surgery was necessary.
CONCLUSIONS: With the microsurgical method of pinpoint ablation of the trabecular meshwork by excimer laser, intraocular pressure was reduced in 30 of 35 eyes over a median follow-up period of 7 months. These results encourage us to continue the development of this procedure, perhaps with a microendoscope. The minimal trauma to the eye of this procedure leaves all other options of surgery open.

Entities:  

Mesh:

Year:  1997        PMID: 9410236     DOI: 10.1007/s003470050180

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  11 in total

1.  Excimer laser trabeculotomy: a new, minimally invasive procedure for patients with glaucoma.

Authors:  Sonja Wilmsmeyer; Heiko Philippin; Jens Funk
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-10-19       Impact factor: 3.117

2.  [Combined cataract and glaucoma surgery. Trabeculectomy vs Erb:YAG goniotomy].

Authors:  S Beuerle; H Philippin; J Funk
Journal:  Ophthalmologe       Date:  2006-07       Impact factor: 1.059

Review 3.  [Excimer laser trabeculotomy: minimally invasive glaucoma surgery].

Authors:  S Herdener; M Pache
Journal:  Ophthalmologe       Date:  2007-08       Impact factor: 1.059

Review 4.  Selective laser trabeculoplasty (SLT) vs other treatment modalities for glaucoma: systematic review.

Authors:  C McAlinden
Journal:  Eye (Lond)       Date:  2013-12-06       Impact factor: 3.775

5.  [One-year results after combined cataract surgery and excimer laser trabeculotomy for elevated intraocular pressure].

Authors:  M Töteberg-Harms; P P Ciechanowski; C Hirn; J Funk
Journal:  Ophthalmologe       Date:  2011-08       Impact factor: 1.059

6.  Combined cataract and glaucoma surgery: endoscope-controlled erbium:YAG-laser goniotomy versus trabeculectomy.

Authors:  Heiko Philippin; Sonja Wilmsmeyer; Nicolas Feltgen; Thomas Ness; Jens Funk
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-02-02       Impact factor: 3.117

7.  Advances in Excimer Laser Trabeculostomy within the Landscape of Minimally-Invasive Glaucoma Surgery.

Authors:  Anne Nguyen; Brian Simon; Rebecca Doan; Emily Chen; Ryan Lamrani; Jonathan Shakibkhou; Michael S Berlin
Journal:  J Clin Med       Date:  2022-06-17       Impact factor: 4.964

8.  An Alternate Technique for Goniotomy: Description of Procedure and Preliminary Results.

Authors:  Thomas Shute; Wesley Green; James Liu; Arsham Sheybani
Journal:  J Ophthalmic Vis Res       Date:  2022-04-29

9.  Cataract surgery combined with excimer laser trabeculotomy to lower intraocular pressure: effectiveness dependent on preoperative IOP.

Authors:  Marc Töteberg-Harms; James Vm Hanson; Jens Funk
Journal:  BMC Ophthalmol       Date:  2013-06-24       Impact factor: 2.209

Review 10.  Glaucoma: Biological Trabecular and Neuroretinal Pathology with Perspectives of Therapy Innovation and Preventive Diagnosis.

Authors:  Raffaele Nuzzi; Federico Tridico
Journal:  Front Neurosci       Date:  2017-09-05       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.